31 March 2022
Our CAR T-cell Research Team talks to Claire Concannon from RNZ's Our Changing World about how we're building the future of cancer treatment in New Zealand.
Dr Patricia Rubio-Reyes, PhD Student Yasmin Nouri and Dr Rachel Perret are part of the Malaghan Institute's Freemasons CAR T-cell Research Programme. Their work, running in parallel to the Institute's CAR T-cell clinical trial, aims to both better understand this groundbreaking therapy at the molecular level, as well as develop ways to improve its safety and widen the scope of the therapy to treat more cancers in the future.
Related articles
Significant milestone reached in first NZ CAR T-cell trial as preparations made for larger phase 2 registration trial
25 March 2024
Read more
RNZ: Engineering immune cells to kill cancer
5 November 2023
Read more
BioOra appoints CAR T-cell therapy pioneer, Professor Carl June to Board
31 October 2023
Read more
In Focus: Mastering the technology behind automated CAR T-cell manufacture
14 September 2023
Read more
RNZ: New Zealand developed cancer treatment one step closer to market
17 May 2023
Read more
Malaghan PhD student receives Māori Cancer Researcher Award
28 April 2023
Read more